DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Cherian JJ, Parvizi J, Bramlet D. et al.
Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-beta1 in patients with grade 3 chronic degenerative joint disease of the knee.
Osteoarthritis Cartilage 2015;
23: 2109-2118
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.